Filippini, Federica
 Distribuzione geografica
Continente #
NA - Nord America 146
EU - Europa 140
AS - Asia 41
OC - Oceania 1
Totale 328
Nazione #
US - Stati Uniti d'America 146
IT - Italia 87
HK - Hong Kong 28
FI - Finlandia 19
CN - Cina 11
DE - Germania 11
IE - Irlanda 8
GB - Regno Unito 7
SE - Svezia 3
RS - Serbia 2
AU - Australia 1
ES - Italia 1
FR - Francia 1
IN - India 1
LK - Sri Lanka 1
PL - Polonia 1
Totale 328
Città #
Chandler 36
Hong Kong 28
New York 18
Brescia 17
Rome 14
Helsinki 13
Milan 13
Princeton 10
Fairfield 9
Shanghai 9
Dublin 8
Seattle 7
Lappeenranta 6
Woodbridge 5
Ashburn 4
Cagliari 4
Cassano Magnago 4
Turin 4
Cambridge 3
Houston 3
Kilburn 3
Latina 3
Naples 3
Nuoro 3
Barbarano Vicentino 2
Beijing 2
Belgrade 2
Bologna 2
Catania 2
Des Moines 2
Fucecchio 2
Jacksonville 2
Los Angeles 2
Padova 2
San Diego 2
Trevenzuolo 2
Ann Arbor 1
Barcelona 1
Boscotrecase 1
Cardito 1
Chicago 1
Colombo 1
Falkenstein 1
Ferrara 1
Glasgow 1
Hamburg 1
London 1
New Bedfont 1
Phoenix 1
Rovato 1
Southwark 1
Warsaw 1
Totale 267
Nome #
VALUTAZIONE DELLA RISPOSTA UMORALE E CELLULO-MEDIATA CONTRO SARS-COV-2 EVOCATA DAL VACCINO PFIZER mRNA BNT162b2 IN PAZIENTI IMMUNOSOPPRESSI. 79
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 51
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 47
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 33
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 26
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 17
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 17
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 15
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 13
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 12
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 11
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 10
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 8
Totale 339
Categoria #
all - tutte 3.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 15 7 2 3 2 1
2021/202239 1 8 3 2 0 0 1 8 1 1 4 10
2022/2023117 6 2 2 5 9 25 0 10 21 6 20 11
2023/2024153 14 4 19 16 11 18 14 14 32 5 6 0
Totale 339